Correlation between saliva production and quality of life measurements in head and neck cancer patients treated with intensity-modulated radiotherapy

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 30, Issue 3, 2007, Pages 271-277

  Scrimger, Rufus ^a,c   Kanji, Aliyah ^b   Parliament, Matthew ^a   Warkentin, Heather ^a   Field, Colin ^a   Jha, Naresh ^a   Hanson, John ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c CROSS CANCER INSTITUTE   (Canada)

Author keywords

Head and neck carcinoma; Intensity modulated radiotherapy (IMRT); Quality of life (QOL); Xerostomia

Indexed keywords

PLATINUM DERIVATIVE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; CORRELATION ANALYSIS; DATA ANALYSIS; FEMALE; HEAD AND NECK CANCER; HUMAN; INFORMATION PROCESSING; INTENSITY MODULATED RADIATION THERAPY; LARYNX; MALE; MOUTH CAVITY; NASOPHARYNX; OROPHARYNX; QUALITY OF LIFE; QUESTIONNAIRE; SALIVA ANALYSIS; SALIVARY GLAND; SALIVATION; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; XEROSTOMIA;

CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; RADIOTHERAPY; RADIOTHERAPY DOSAGE; SALIVATION; XEROSTOMIA;

EID: 34250008218     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/01.coc.0000258081.70643.3d     Document Type: Article

References (20)

1. Chao KSC, Low DA, Perez CA, et al. Intensity-modulated radiation therapy in head and neck cancers: the Mallinckrodt experience. Int J Cancer. 2000;90:92-103.
2. Butler EB, Teh BS, Grant WH, et al. SMART (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fraction schedule for the treatment of head and neck cancer with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 1999;45:21-32.
3. Claus F, Duthoy W, Boterberg T, et al. Intensity modulated radiation therapy for oropharyngeal and oral cavity tumors: clinical use and experience. Oral Oncol. 2002;38:597-604.
4. Hassan SJ, Weymuller EA Jr. Assessment of quality of life in head and neck cancer patients. Head Neck. 1993;15:485-496.
5. Fox PC, Busch KA, Baum BJ. Subjective reports of xerostomia and objective measurements of salivary gland performance. J Am Dent Assoc. 1987;115:581-584.
6. Eisbruch A, Ship JA, Martel MK, et al. Parotid gland sparing in patients undergoing bilateral head and neck irradiation: techniques and early results. Int J Radiat Oncol Biol Phys. 1996;36:469-480.
7. Parliament MB, Scrimger RA, Anderson SG, et al. Preservation of oral health-related quality of life and saliva flow rates after inverse-planned intensity-modulated radiotherapy (IMRT) for head and neck cancer. Int J Radiat Oncol Biol Phys. 2004;58:663-673.
8. Dawes C. How much saliva is enough for avoidance of xerostomia? Caries Res. 2004;38:236-240.
9. Ringash J, Wardie P, Lockwood G, et al. Postradiotherapy quality of life for head-and-neck cancer patients is independent of xerostomia. Int J Radiat Oncol Biol Phys. 2005;61:1403-1407.
10. Harrison LB, Zelefsky MJ, Pfister DG, et al. Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue. Head Neck. 1997;19:169-175.
11. Talmi YP, Horowitz Z, Bedrin B, et al. Quality of life of nasopharyngeal carcinoma patients. Cancer. 2002;94:1012-1017.
12. Hammerlid E, Taft C. Health-related quality of life in long-term head and neck cancer survivors: a comparison with general population norms. Br J Cancer. 2001;84:149-156.
13. Jabbari S, Kim HM, Feng M, et al. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy for head and neck cancer: initial report. Int J Radiat Oncol Biol Phys. 2005;63:725-731.
14. Lee N, Xia P, Quivey JM, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys. 2002;53:12-22.
15. Dawson L, Anzai Y, Marsh L, et al. Patterns of local-regional recurrence following parotid-sparing conform and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2000;46:1117-1126.
16. Chao KSC, Ozyigit G, Tran B, et al. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2003;55:312-321.
17. Wu Q, Manning M, Schmidt-Ullrich R, et al. The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study. Int J Radiat Oncol Biol Phys. 2000;46:195-205.
18. Taylor SE. Efficacy and economic evaluation of pilocarpine in treating radiation-induced xerostomia. Exp Opin Pharmacother. 2003;4:1489-1497.
19. Burlage FR, Coppes RP, Meertens H, et al. Parotid and submandibular/sublingual salivary flow during high-dose radiotherapy. Radiother Oncol. 2001;61:271-274.
20. Jha N, Seikaly H, Harris J, et al. Prevention of radiation-induced xerostomia by surgical transfer of submandibular salivary gland into the submental space. Radiother Oncol. 2003;66:283-289.